Bold Pursuits in Health and Well-Being

Body and Soul: Bold pursuits in health and the arts. Includes an image of a large copper shell sculpture.
March 20, 2023
College of Pharmacy Dean Sam Poloyac participated in a panel discussion from the 2023 Texas Leadership Society Luncheon on The University of Texas at Austin's bold pursuits in health and well-being. The discussion was moderated by UT President Jay Hartzell.

Fiercely Focused | iCAN

A woman wearing pearls and a dark outfit.
March 15, 2023
Dr. Leticia R. Moczygemba in the Division of Health Outcomes talked to ECHO, an agency that plans and implements community-wide strategies to end homelessness in Austin and Travis County, about the Interactive Care Coordination and Navigation (iCAN) program that studies how getting phones to more people living outside impacts their lives and health outcomes.

Moczygemba and Janzen Earn Promotions

Two women smiling while both wear dark clothing.
February 27, 2023
Two of the college's distinguished faculty in the Division of Health Outcomes and Division of Pharmacy Practice were recommended for promotion by President Hartzell due to their outstanding accomplishments in research, outreach and education. Dr. Tish Moczygemba will assume the rank of professor and Dr. Kristin Janzen will become a clinical associate professor.

AAPS Addresses “Infodemic,” Scientific Credibility and the Public On TV

A man wearing a suit, a man in a patterned shirt smiling, and a woman wearing pearls.
November 4, 2022
Leaders from the American Association of Pharmaceutical Scientists (AAPS), including the College of Pharmacy's Dr. Robert O. (Bill) Williams III, address the “infodemic” and AAPS’ role in evaluating and bringing attention to credible science on a November 5 episode of "Advancements with Ted Danson."

College of Pharmacy Researchers Share Latest Findings on Novel Drug Delivery Technology

Five nasal inhalers with their caps on.
October 31, 2022
Researchers in the lab of Dr. Robert O. (Bill) Williams III, Division Head and Professor of Molecular Pharmaceutics and Drug Delivery at the College of Pharmacy, are advancing an innovative platform technology known as Thin Film Freezing, which could revolutionize administration, distribution and access to both vaccines and therapies.

PharmE3D Labs Earn National and International Accolades

Brick facade of Pharmacy building with affixed text, "The University of Texas at Austin College of Pharmacy"
July 11, 2022
Researchers in UT Pharmacy's Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have earned a bevy of national and international awards for their work in pharmaceutical drug delivery and 3D printing personalized medicines.

Celebrating the Latest Awards, Appointments and Achievements from the UT Pharmacy Community

Pharmacy building on UT campus
July 5, 2022
From student scholarships to national recognition awards to prestigious appointments, the UT Pharmacy community has a lot to celebrate and be proud of right now.

PharmE3D Labs Receive Federal Funding for 3D Printed Contraception

Four people wearing masks and lab coats.
March 14, 2022
Dr. Mo Maniruzzaman's Pharmaceutical Engineering and 3D Printing Labs have received a federal grant from the United States Agency for International Development (USAID) to develop personalized 3D printed non-hormonal intrauterine devices (IUDs). The project’s goal is to increase global access to long-term and effective contraception while minimizing some of its most debilitating side effects.

Moczygemba and Wash Earn 2022 Kloesel Grant

A woman and a man smiling.
January 11, 2022
Leticia "Tish" Moczygemba, Pharm.D., Ph.D. and Andrew Wash, Pharm.D. were selected as the recipients of the 2022 grant award from the Arlyn Kloesel Endowment for Excellence in Pharmacy Practice.

PharmE3D Labs Receive R01 Grant for Complex Vaccine Technologies

Three people smiling.
September 24, 2021
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.